- Home
- HBNC vs DAWN Comparison
HBNC vs DAWN Comparison
Compare HBNC & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBNC
- DAWN
- Stock Information
- Founded
- HBNC 1873
- DAWN 2018
- Country
- HBNC United States
- DAWN United States
- Employees
- HBNC N/A
- DAWN N/A
- Industry
- HBNC Major Banks
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- HBNC Finance
- DAWN Health Care
- Exchange
- HBNC Nasdaq
- DAWN Nasdaq
- Market Cap
- HBNC 708.6M
- DAWN 658.9M
- IPO Year
- HBNC N/A
- DAWN 2021
- Fundamental
- Price
- HBNC $15.88
- DAWN $6.38
- Analyst Decision
- HBNC Hold
- DAWN Strong Buy
- Analyst Count
- HBNC 2
- DAWN 6
- Target Price
- HBNC $17.00
- DAWN $30.17
- AVG Volume (30 Days)
- HBNC 178.6K
- DAWN 1.4M
- Earning Date
- HBNC 07-23-2025
- DAWN 07-29-2025
- Dividend Yield
- HBNC 4.02%
- DAWN N/A
- EPS Growth
- HBNC 88.54
- DAWN N/A
- EPS
- HBNC 1.02
- DAWN N/A
- Revenue
- HBNC $201,164,000.00
- DAWN $161,922,000.00
- Revenue This Year
- HBNC $46.44
- DAWN $17.98
- Revenue Next Year
- HBNC $4.83
- DAWN $49.50
- P/E Ratio
- HBNC $15.60
- DAWN N/A
- Revenue Growth
- HBNC 11.46
- DAWN N/A
- 52 Week Low
- HBNC $12.70
- DAWN $6.08
- 52 Week High
- HBNC $19.18
- DAWN $16.76
- Technical
- Relative Strength Index (RSI)
- HBNC 58.02
- DAWN 44.72
- Support Level
- HBNC $15.29
- DAWN $6.48
- Resistance Level
- HBNC $15.97
- DAWN $7.00
- Average True Range (ATR)
- HBNC 0.41
- DAWN 0.28
- MACD
- HBNC -0.02
- DAWN -0.02
- Stochastic Oscillator
- HBNC 58.40
- DAWN 14.77
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.